Avantor (AVTR) | Financial Analysis & Statements
Avantor Inc. Mid-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
1.7B
Gross Profit
523.9M
31.49%
Operating Income
131.5M
7.90%
Net Income
52.4M
3.15%
Balance Sheet Metrics
Total Assets
11.8B
Total Liabilities
6.2B
Shareholders Equity
5.6B
Debt to Equity
1.12
Cash Flow Metrics
Operating Cash Flow
109.8M
Free Cash Flow
117.2M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Avantor Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 6.6B | 6.8B | 7.0B | 7.5B | 7.4B |
| Cost of Goods Sold | 4.4B | 4.5B | 4.6B | 4.9B | 4.9B |
| Gross Profit | 2.1B | 2.3B | 2.4B | 2.6B | 2.5B |
| Gross Margin % | 32.7% | 33.6% | 33.9% | 34.6% | 33.9% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 1.6B | 1.6B | 1.5B | 1.5B | 1.5B |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 1.6B | 1.6B | 1.5B | 1.5B | 1.5B |
| Operating Income | 543.9M | 638.2M | 857.2M | 1.1B | 972.2M |
| Operating Margin % | 8.3% | 9.4% | 12.3% | 15.0% | 13.2% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | 169.8M | 218.8M | 284.8M | 265.8M | 217.4M |
| Other Non-Operating Income | -815.4M | 434.5M | -161.9M | -13.3M | -1.8M |
| Pre-tax Income | -441.3M | 853.9M | 410.5M | 851.1M | 753.0M |
| Income Tax | 88.9M | 142.4M | 89.4M | 164.6M | 180.4M |
| Effective Tax Rate % | 0.0% | 16.7% | 21.8% | 19.3% | 24.0% |
| Net Income | -530.2M | 711.5M | 321.1M | 686.5M | 572.6M |
| Net Margin % | -8.1% | 10.5% | 4.6% | 9.1% | 7.8% |
| Key Metrics | |||||
| EBITDA | 941.1M | 1.0B | 1.3B | 1.5B | 1.4B |
| EPS (Basic) | $-0.78 | $1.05 | $0.48 | $1.02 | $0.86 |
| EPS (Diluted) | $-0.78 | $1.04 | $0.47 | $1.01 | $0.85 |
| Basic Shares Outstanding | 680600000 | 679600000 | 675600000 | 650900000 | 590500000 |
| Diluted Shares Outstanding | 680600000 | 679600000 | 675600000 | 650900000 | 590500000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Avantor Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 365.4M | 261.9M | 262.9M | 372.9M | 301.7M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 1.1B | 1.0B | 1.2B | 1.2B | 1.2B |
| Inventory | 818.2M | 731.5M | 828.1M | 913.5M | 872.0M |
| Other Current Assets | 193.0M | 118.7M | 143.7M | 153.1M | 81.4M |
| Total Current Assets | 2.5B | 2.1B | 2.4B | 2.7B | 2.5B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 13.2B | 14.4B | 15.2B | 15.4B | 15.8B |
| Intangible Assets | 3.2B | 3.4B | 3.8B | 4.1B | 5.1B |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 396.0M | 360.4M | 358.3M | 293.5M | 233.1M |
| Total Non-Current Assets | 9.3B | 10.0B | 10.6B | 10.8B | 11.4B |
| Total Assets | 11.8B | 12.1B | 13.0B | 13.5B | 13.9B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 741.7M | 662.8M | 625.9M | 758.2M | 755.1M |
| Short-term Debt | 30.8M | 821.1M | 259.9M | 364.2M | 45.2M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 396.4M | 306.8M | 411.2M | 364.1M | 401.0M |
| Total Current Liabilities | 1.4B | 2.0B | 1.5B | 1.7B | 1.5B |
| Non-Current Liabilities | |||||
| Long-term Debt | 3.9B | 3.2B | 5.3B | 5.9B | 7.0B |
| Deferred Tax Liabilities | 557.1M | 557.3M | 612.8M | 731.4M | 913.0M |
| Other Non-Current Liabilities | 378.2M | 358.3M | 350.3M | 295.4M | 358.4M |
| Total Non-Current Liabilities | 4.9B | 4.2B | 6.2B | 7.0B | 8.2B |
| Total Liabilities | 6.2B | 6.2B | 7.7B | 8.6B | 9.7B |
| Equity | |||||
| Common Stock | 4.0B | 3.9B | 3.8B | 3.8B | 2.8B |
| Retained Earnings | 1.7B | 2.2B | 1.5B | 1.2B | 483.9M |
| Treasury Stock | 75.7M | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 5.6B | 6.0B | 5.3B | 4.9B | 4.2B |
| Key Metrics | |||||
| Total Debt | 3.9B | 4.1B | 5.5B | 6.3B | 7.0B |
| Working Capital | 1.1B | 139.1M | 904.6M | 999.1M | 1.0B |
Balance Sheet Composition
Avantor Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -530.2M | 711.5M | 321.1M | 686.5M | 572.6M |
| Depreciation & Amortization | 410.2M | 405.5M | 402.3M | 405.5M | 379.2M |
| Stock-Based Compensation | 46.4M | 46.8M | 40.5M | 45.8M | 50.7M |
| Working Capital Changes | -197.6M | 49.3M | 16.3M | -321.4M | -119.8M |
| Operating Cash Flow | -253.1M | 1.2B | 620.1M | 756.0M | 884.3M |
| Investing Activities | |||||
| Capital Expenditures | - | - | - | - | - |
| Acquisitions | 0 | 585.2M | 0 | -20.2M | -4.0B |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | 0 | 0 | 42.5M | 0 |
| Investing Cash Flow | -1.7M | 587.7M | 2.7M | 23.8M | -4.0B |
| Financing Activities | |||||
| Share Repurchases | -80.7M | -8.6M | -13.7M | -13.2M | -25.8M |
| Dividends Paid | - | 0 | 0 | -32.4M | -64.6M |
| Debt Issuance | 1.1B | 0 | 0 | 327.2M | 2.8B |
| Debt Repayment | -1.4B | -1.3B | -846.0M | -947.0M | -533.9M |
| Financing Cash Flow | -414.5M | -1.4B | -862.0M | -666.0M | 3.1B |
| Free Cash Flow | 495.0M | 692.0M | 723.6M | 710.2M | 842.5M |
| Net Change in Cash | -669.3M | 431.3M | -239.2M | 113.8M | 10.4M |
Cash Flow Trend
Avantor Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
14.85
Forward P/E
9.09
Price to Book
0.94
Price to Sales
0.81
PEG Ratio
-0.17
Profitability Ratios
Profit Margin
-8.09%
Operating Margin
10.17%
Return on Equity
-9.20%
Return on Assets
2.96%
Financial Health
Current Ratio
1.78
Debt to Equity
74.25
Beta
1.00
Per Share Data
EPS (TTM)
$-0.78
Book Value per Share
$8.24
Revenue per Share
$9.63
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| AVTR | 5.3B | 14.85 | 0.94 | -9.20% | -8.09% | 74.25 |
| Intuitive Surgical | 170.1B | 54.97 | 8.99 | 16.69% | 28.38% | 0.95 |
| Becton, Dickinson | 56.1B | 25.40 | 1.75 | 6.96% | 8.01% | 77.28 |
| Baxter International | 9.4B | 86.31 | 1.54 | -13.71% | -8.51% | 160.28 |
| AptarGroup | 8.0B | 21.10 | 2.99 | 15.10% | 10.40% | 57.10 |
| Repligen | 7.5B | 154.30 | 3.55 | 2.40% | 6.62% | 32.76 |
Financial data is updated regularly. All figures are in the company's reporting currency.






